Subscribe to Newsletter

Drug Discovery

Discovery & Development Drug Discovery

Recycling for ROP

| Jamie Irvine, Alun Evans | 2 min read

K604 offer potential new treatment for ROP

Discovery & Development Drug Discovery

IOP Control – with Gene Therapy

| 3 min read

Novel Gene Therapy shows promise for treating intraocular pressure of glaucoma

Discovery & Development Drug Discovery

The Dangers of Dengue

| Neelika Malavige | 4 min read

We need more investment for research into dengue treatments that can curb the overwhelming pressure placed on healthcare systems.

Discovery & Development Drug Discovery

Nut a Problem

| Jamie Irvine | 2 min read

Immunotherapy Viaskin Peanut shows promising results in desensitizing peanut-allergic toddlers.

Discovery & Development Drug Discovery

Cancer Treatments for Kids

| Jamie Irvine | 5 min read

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases

Discovery & Development Drug Discovery

Cell Therapy Team Up

| Jamie Irvine | 2 min read

Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development

Discovery & Development Drug Discovery

Lung Cancer Collaboration

| Jamie Irvine | 2 min read

The Lung Cancer Research Foundation has partnered with Daiichi Sankyo and AstraZeneca to offer grants for research exploring ADCs against lung cancer

Discovery & Development Drug Discovery

How Custom Antibody Libraries Empower Therapeutic Antibody Bioassays

| Sponsored by Bio-Rad Laboratories | 6 min read

There are many ways to generate antibodies, but sometimes traditional methods don’t deliver what you need.

Discovery & Development Drug Delivery

Power List Perspectives: Challenges Facing Cell and Gene Therapy

| Jamie Irvine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

Discovery & Development Drug Discovery

Meet the New Wave of Therapeutic Antibodies

| Sponsored by Bio-Rad Laboratories | 6 min read

How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register